At a glance
ClinicalIndex Comparison RecordN/ACompleted· 150 enrolled
Drug / intervention
Intensive care cirrhosis outcome (ICCO) scoreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Study of the Validity of Intensive Care Cirrhosis Outcome Score (ICCO) in Predicting Outcome in Cirrhotic Patients Admitted to Intensive Care Unit.
In Brief
An observational study evaluating Intensive care cirrhosis outcome (ICCO) score for Liver Cirrhosis. Completed, enrolled 150 participants across 1 site.
Detailed Summary
This study aims at calculating a specific score to cirrhotic patients admitted at ICU (ICCO score) and use this score to predict mortality and outcome for admitted patients.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLiver Cirrhosis
CountriesEgypt
Collaborators--
Timeline
N/ACompletedFinished
20252026
First PostedAug 2024
Enrollment StartMar 2025
Primary CompletionJan 2026
Study CompletionFeb 2026
TodayJul 2026
First PostedAug 20, 2024
Enrollment StartMar 1, 2025
Primary CompletionJan 2, 2026
Study CompletionFeb 6, 2026
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 1.9 years ago
Interventions
Intensive care cirrhosis outcome (ICCO) scoreother
ICCO score will be calculated for the participants to use it as a predictor for mortality and ICU outcome The ICCO score is 0.3707 + (0.0773 x bilirubin (mg/dl)) - (0.00849 x cholesterol (mg/dl)) -(0.0155 x creatinine clearance (ml/min)) + (0.1351 x lactate (mmol/l))